Enforcement

Publishing a medical, drug or medical device advertisement in breach of article 16 attracts an order to stop publication and eliminate the effects, a fine of one to three times the advertising cost (or 100,000 to 200,000 yuan where the cost cannot be calculated), and in serious cases three to five times the cost (or 200,000 to 1,000,000 yuan), possible revocation of the business licence, revocation of the advertising approval document and refusal to accept further advertising review applications for one year.

第16条に違反する医療・医薬品・医療機器広告を発布した者には、発布停止と影響除去の命令に加え、広告費用の1倍以上3倍以下（算定不能等の場合は10万元以上20万元以下）の過料が科され、情状が重い場合は3倍以上5倍以下（20万元以上100万元以下）、営業許可の取消し、広告審査批准文書の取消しおよび1年間の審査申請不受理が科される。